BCBS of North Carolina CEO: Pandemic costs will be ‘north of $600M’

The COVID-19 pandemic will cost Blue Cross and Blue Shield of North Carolina more than it expected, the health insurer’s new CEO Tunde Sotunde, MD, told The News & Observer. 

Advertisement

Dr. Sotunde predicts the health insurer will shoulder “north of $600 million” in COVID-19-related costs, based on modeling that accounts for a resurgence in COVID-19 cases in recent weeks. 

More than half of the costs are related to steps BCBS of North Carolina took to eliminate member cost-sharing for COVID-19 screening, testing and treatment. Other costs included expanded telehealth services, grace periods for premium payments and accelerated claim payments.

Dr. Sotunde said BCBS of North Carolina is in a position to weather the costs, but it’s unclear if they will lead to premium increases next year.

Read more here. 

More articles on payers:
UnitedHealth’s earnings double in Q2 as patients deferred elective procedures
BCBS of Massachusetts launches global payment model for primary care clinics
Optum’s revenue grows to $33B in Q2: 5 things to know

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Advertisement

Next Up in Payer

Advertisement

Comments are closed.